We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| North American | NAM | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 154.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 154.00 | 154.00 |
| Top Posts |
|---|
Posted at 23/10/2006 12:10 by energyi Last Updated: 10/23/2006 Symbol: NAM Exchange: TSX Venture Current Share Price: $0.52 Shares Outstanding: 32.6 million Shares Fully Diluted: 46.5 million 52 Week Range (Lo - Hi): $0.30 - 0.62 Market Capitalization: $16.952 million = = SUBJECT: Toronto Resource Investment Conference Posted By: pyoing Post Time: 9/25/2006 22:28 I attended the conference and listened to the Nam corporate presentation given by Tommy Cheng CEO. Most of what Tommy spoke is already on their website, but there were a few additions that some may find useful. - there will be a NI43-101 due out November. - 2007: 10,000oz. gold to be poured, with an additional 5,000oz. from newly acquired properties. - US. OTC.BB listing is not being considered by NAM, but in the future the company does want to graduate from the Frankfurt onto Hong Kong exchange. - over a $million in the kitty. 2/ SUBJECT: RE: Toronto Resource Investment Conference Posted By: joemanner Post Time: 9/25/2006 22:42 The conference is informative to me as they have some new exciting projects due to have news coming out soon. I found out a new surge on projects on China after reading the Northern Miner issue on the China/ Mongolia. NAM is definitely among one of them as it has featured, not bad for a Company only listed for less than 6 months! 3/ SUBJECT: RE: Toronto Resource Investment Conference Posted By: BillyMiner Post Time: 9/28/2006 15:38 I spoke to the guys at the show as well. NAM has poured 400 oz of gold already from the Majiahe Property and will most likely get about 2000 oz in total from that project this year. As Pyoing said, they will get another 10,000 oz next year. The newly acquired property will also have production. They have an amazing exploration property (Xuefeng Property) with huge potential and they are currently working on a 43-101 for it. I got the feeling that they are also looking at some other properties to acquire as well. This company has awesome potential for the short and long term. Billy |
Posted at 15/10/2001 13:26 by cat man 0007I've got closing prices for NAM going back to 1994 if that's far enough for you. Post your e-mail address and I'll forward it later in the week as I'm incommunicado after 2:30pm for the next 2 days. :-) CM |
Posted at 15/10/2001 09:39 by wild_cat has nam been suspended? cant get any quotes on this and no trades. |
Posted at 11/9/2001 13:21 by spiceboy time to go short on NAM...target 5 quid, stop 600 |
Posted at 10/9/2001 20:23 by crontab time to go long on nam...target 7 quid, stop 550 |
Posted at 07/8/2001 09:05 by zzaxx99 for TCFKANA (The Company Formerly Known as Nycomed Amersham)'.... HIGHLIGHTSSales up 13% to £783 million, earnings per share up 10% to 13.6pImaging sales up 13% to £458 million, driven by growing markets and focus on major disease areasAccelerated growth in portfolio of patented products: sales up 28% to £144 millionGrowth of unpatented products: sales up 10% to £174 millionAmersham Pharmacia Biotech sales up 13% to £325 millionDrug discovery sales up 9% to £71 million: good growth in proteomics, held back by sequencingContinued strong performance in separations, driven by growing sales of biopharmaceuticals and focus on the study of proteins: sales up 22% to £130 million ......' |
Posted at 31/7/2001 16:03 by spiceboy MM, are we still on the trading here, or is this one of the "late night confessions" threads! :-)No, out of NAM - I moved my trailing stop in close when it struggled to break through 500. Got taken out on the way up to 522ish at the start of July. Very nice trade for me - the charting was perfect, entered at correct time, used my stops well, got taken out by my trailing stop. Lots of discipline for a change - don't know what went wrong, er right! SpiceBoy |
Posted at 14/6/2001 12:30 by spiceboy OK, here's the story of the last 6 weeks from a NAM perspective...nothinSitting in the range 540ish - 570ish, some days it goes up a bit, some days it goes down a bit! It really needs to move decisively out of this range to indicate a clear direction. I'm still short, but if I wasn't I'd be waiting for a break either way. Really a close above 580 or below 530 would do it for me (although we did open at 581 and reach 586 a few days back, but I generally wait for a close to confirm direction...) Cheers, SpiceBoy |
Posted at 04/6/2001 11:11 by zzaxx99 'New Generation of Prostate Brachytherapy Seeds Strengthens Company'sLeadership Position in Seed Implant Therapy for Prostate Cancer London, June 4, 2001-Nycomed Amersham (LSE:NAM; NYSE:NYE), the world leader in brachytherapy implants for prostate cancer announced it has received FDA clearance and all other regulatory approvals in the U.S. required to market EchoSeed (Iodine-125), a new generation of brachytherapy seed that will maximize patient care. EchoSeed's patented technology utilizes conventional ultrasound imaging, to provide physicians with more information about seed placement during the course of an implant procedure. "EchoSeed represents the first true breakthrough in brachytherapy treatment since the introduction of RAPID Strand in 1995 and will reinforce Nycomed Amersham's leadership position in the U.S.," said John Jeans, President of Nycomed Amersham Imaging's Therapy Products business. "EchoSeed was developed after feedback from leading practitioners in prostate brachytherapy who wanted more immediate visual information about seed placement during the course of a prostate implant, using currently available imaging technology. Extensive market research among physicians verified EchoSeed's strong market potential," added Mr. Jeans. EchoSeed's patented grooved design in combination with conventional ultrasound imaging allows the physician to view both the prostate gland and EchoSeed during an implant procedure. The physician is able to see more of the seeds during the implant procedure thus facilitating optimal placement into the prostate. EchoSeed will be launched later today at the American Urological Association Annual Meeting in Anaheim, California. Nycomed Amersham is the world leader in brachytherapy implants, used to treat prostate cancer. The company's product portfolio includes OncoSeed, (brand of Iodine-125 prostate brachytherapy seeds) the world's leading prostate implant seed for the treatment of prostate cancer and TheraSeed, the world's leading palladium-103 brachytherapy seed. In addition, the company markets its proprietary RAPID Strand ideally suited for the treatment of extraprostatic extension of prostate cancer; (disease, that affects the area just outside the prostate). ...' |
Posted at 31/5/2001 18:28 by aquila Brain, thanks for that, I guess a lot of people are the same using a mix, although the traders will bring out the silver bullets at the mention of the "F" word ;) So you must give more credence to charts than the 50/50 coin flip! ( Mind you the coin works for me sometimes) Glad there's someone else trading DGE ! It needs to get out of this area, either south of the 660 or north of 792 ! We'll see. The trading is good thank you. I take it you're long NAM ? regards, A. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
